Internal Medicine, Endocrinology, Diabetes, & Metabolism · Medford, OR
NPI
1114993656
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
691 Murphy Road, Suite 107
Medford, OR, 97504
Phone (541) 789-6460
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
1,265 services
Medicare patients, 2024
682
Average age 74
Drug cost, 2024
$1.9M
5,349 prescriptions
Company payments, 2025
$456
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John T Gallen was code 99214 (office e&m - established), 452 times for 399 patients. In total John T Gallen billed 1,265 services in 13 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 452 | 399 | $83.52 | $38K |
| 99214 Office E&M - Established | Facility | 286 | 271 | $77.62 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 102 | 94 | $13.46 | $1,373 |
| 95251 Test - Miscellaneous | Office | 89 | 72 | $26.79 | $2,385 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 72 | 69 | $13.59 | $978 |
| 95251 Test - Miscellaneous | Facility | 65 | 56 | $27.66 | $1,798 |
| 99204 Office E&M - New | Facility | 51 | 51 | $105.10 | $5,360 |
| 99204 Office E&M - New | Office | 35 | 35 | $119.76 | $4,191 |
| 99213 Office E&M - Established | Facility | 24 | 23 | $54.14 | $1,299 |
| 99213 Office E&M - Established | Office | 24 | 24 | $69.00 | $1,656 |
| 82962 Clinical Chemistry | Office | 16 | 16 | $3.21 | $51.36 |
| 99211 Office E&M - Established | Facility | 12 | 11 | $7.21 | $86.52 |
By year: 2022 $123K for 2,250 services; 2023 $91K for 1,267 services; 2024 $82K for 1,265 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 16 | 16 | $3.21 | $51.36 |
Medicare prescription drug claims, 2024
In 2024, the drug John T Gallen prescribed most often to Medicare patients was Levothyroxine Sodium, with 927 prescriptions and refills. In total John T Gallen wrote 5,349 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 927 | 2,378 | 232 | $11K |
| Alendronate Sodium Generic | 262 | 678 | 80 | $3,391 |
| Jardiance Empagliflozin | 219 | 458 | 54 | $257K |
| Testosterone Cypionate Generic | 203 | 297 | 45 | $7,418 |
| Glimepiride Generic | 200 | 449 | 55 | $2,334 |
| Ozempic Semaglutide | 185 | 302 | 51 | $277K |
| Methimazole Generic | 174 | 436 | 50 | $1,724 |
| Atorvastatin Calcium Generic | 170 | 446 | 47 | $1,936 |
| Metformin Hcl Er Metformin Hcl | 156 | 386 | 50 | $2,018 |
| Metformin Hcl Generic | 149 | 432 | 52 | $1,568 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 142 | 263 | 53 | $29K |
| Hydrocortisone Generic | 129 | 285 | 28 | $7,659 |
| Synthroid Levothyroxine Sodium | 127 | 381 | 36 | $12K |
| Humalog Kwikpen U-100 Insulin Lispro | 96 | 166 | 31 | $41K |
| Semglee (Yfgn) Pen Insulin Glargine-Yfgn | 89 | 133 | 25 | $63K |
Brand drugs: 2,226 claims; generic drugs: 2,869 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John T Gallen $456 ($456 in general payments such as food, travel and fees) from 9 companies. The largest payer was Amgen Inc. with $159.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 7 | $159 |
| Novo Nordisk Inc NVO | 4 | $99.85 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $71.31 |
| Dexcom, Inc. DXCM | 1 | $24.38 |
| Medtronic, Inc. MDT | 1 | $22.59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22.07 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $20.37 |
| Beta Bionics, Inc. BBNX | 1 | $17.95 |
| Sequel Med Tech, LLC | 1 | $17.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.